Cochrane Abstracts
Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Short‐acting Beta2‐agonists for Stable Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436953/all/Short‐acting_beta2‐agonists_for_stable_chronic_obstructive_pulmonary_disease.
Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436953/all/Short‐acting_beta2‐agonists_for_stable_chronic_obstructive_pulmonary_disease. Accessed December 2, 2024.
Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436953/all/Short‐acting_beta2‐agonists_for_stable_chronic_obstructive_pulmonary_disease
Short‐acting Beta2‐agonists for Stable Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436953/all/Short‐acting_beta2‐agonists_for_stable_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease
ID - 436953
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436953/all/Short‐acting_beta2‐agonists_for_stable_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
